Blueprint Medicines to Present at Upcoming Investor Conferences in August
- 38th Annual
Canaccord Genuity Growth Conferencein Boston, MAon Wednesday, August 8, 2018at 3:00 p.m. E.T.
Wedbush PacGrow Healthcare Conferencein New York, NYon Wednesday, August 15, 2018at 9:10 am. E.T.
A live webcast of each presentation will be available by visiting the Investors section of Blueprint Medicines' website at http://ir.blueprintmedicines.com. A replay of the webcast will be archived on Blueprint Medicines' website for 30 days following each presentation.
Blueprint Medicines is developing a new generation of targeted and potent kinase medicines to improve the lives of patients with genomically defined diseases. Its approach is rooted in a deep understanding of the genetic blueprint of cancer and other disease driven by the abnormal activation of kinases.
View original content with multimedia:http://www.prnewswire.com/news-releases/blueprint-medicines-to-present-at-upcoming-investor-conferences-in-august-300690485.html
Investor and Media Relations Contacts: Kristin Hodous, 617-714-6674, KHodous@blueprintmedicines.com; Jim Baker, 617-844-8236, JBaker@blueprintmedicines.com